These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 28468916)
41. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. Han C; Jiang Y; Wang Z; Wang H Int Immunopharmacol; 2019 Aug; 73():10-16. PubMed ID: 31078921 [TBL] [Abstract][Full Text] [Related]
42. Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Youness RA; Rahmoon MA; Assal RA; Gomaa AI; Hamza MT; Waked I; El Tayebi HM; Abdelaziz AI Growth Factors; 2016 Aug; 34(3-4):128-40. PubMed ID: 27388576 [TBL] [Abstract][Full Text] [Related]
43. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
44. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Butterfield LH; Ribas A; Potter DM; Economou JS Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860 [TBL] [Abstract][Full Text] [Related]
45. Natural killer cell activity in hepatocellular carcinoma patients. Lee CS; Lee FZ Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):478-82. PubMed ID: 2551994 [TBL] [Abstract][Full Text] [Related]
46. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414 [TBL] [Abstract][Full Text] [Related]
47. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Chuang WL; Liu HW; Chang WY Cancer; 1990 Feb; 65(4):926-30. PubMed ID: 2153437 [TBL] [Abstract][Full Text] [Related]
48. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma. Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453 [TBL] [Abstract][Full Text] [Related]
49. ZPDC glycoprotein (24 kDa) induces apoptosis and enhances activity of NK cells in N-nitrosodiethylamine-injected Balb/c. Lee J; Lee SJ; Lim KT Cell Immunol; 2014; 289(1-2):1-6. PubMed ID: 24681514 [TBL] [Abstract][Full Text] [Related]
51. Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade. Curran SA; Shyer JA; St Angelo ET; Talbot LR; Sharma S; Chung DJ; Heller G; Hsu KC; Betts BC; Young JW Cancer Immunol Res; 2017 Jan; 5(1):52-60. PubMed ID: 27923824 [TBL] [Abstract][Full Text] [Related]
52. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611 [TBL] [Abstract][Full Text] [Related]
53. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma. Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350 [TBL] [Abstract][Full Text] [Related]
54. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. Zhang P; Lu X; Tao K; Shi L; Li W; Wang G; Wu K J Surg Res; 2015 Mar; 194(1):107-13. PubMed ID: 25450598 [TBL] [Abstract][Full Text] [Related]
55. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma. Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843 [TBL] [Abstract][Full Text] [Related]
56. Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation. Lin D; Lei L; Liu Y; Zhang Y; Hu B; Bao G; Song Y; Jin Z; Liu C; Mei Y; Sandikin D; Wu Y; Zhao L; Yu X; Liu H Cancer Res; 2016 Jun; 76(11):3179-88. PubMed ID: 27206848 [TBL] [Abstract][Full Text] [Related]
57. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma. Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170 [TBL] [Abstract][Full Text] [Related]
58. Relationship between cell membrane potential and natural killer cell cytolysis in human hepatocellular carcinoma cells. Stevenson D; Binggeli R; Weinstein RC; Keck JG; Lai MC; Tong MJ Cancer Res; 1989 Sep; 49(17):4842-5. PubMed ID: 2547520 [TBL] [Abstract][Full Text] [Related]
60. The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells. Allen RP; Ledford BE Cancer Res; 1977 Mar; 37(3):696-701. PubMed ID: 65216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]